Godavari Drugs Limited (GODAVARI.BO)
INR 94.81
(1.86%)
INR 94.81
(1.86%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.34 Billion INR | 10.97% |
| 2022 | 1.21 Billion INR | 19.74% |
| 2021 | 1.01 Billion INR | 11.27% |
| 2020 | 911.39 Million INR | 8.61% |
| 2019 | 839.16 Million INR | 13.8% |
| 2018 | 737.38 Million INR | 17.0% |
| 2017 | 630.23 Million INR | 13.15% |
| 2016 | 557 Million INR | 10.2% |
| 2015 | 505.44 Million INR | 45.49% |
| 2014 | 347.4 Million INR | 127.82% |
| 2013 | 152.49 Million INR | 1.99% |
| 2012 | 149.51 Million INR | 0.0% |
| 2010 | 139.94 Million INR | 10.08% |
| 2009 | 127.13 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 1.27 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 1.34 Billion INR | 0.0% |
| 2023 FY | 1.34 Billion INR | 10.97% |
| 2022 FY | 1.21 Billion INR | 19.74% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 1.23 Billion INR | 0.0% |
| 2022 Q4 | 1.21 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 1.06 Billion INR | 0.0% |
| 2021 FY | 1.01 Billion INR | 11.27% |
| 2021 Q4 | 1.01 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 911.39 Million INR | 8.61% |
| 2020 Q4 | 911.39 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 862.2 Million INR | 0.0% |
| 2019 Q2 | 746.16 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 839.16 Million INR | 13.8% |
| 2019 Q4 | 839.16 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q4 | 737.38 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 685.42 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 737.38 Million INR | 17.0% |
| 2017 Q4 | 630.23 Million INR | 0.0% |
| 2017 Q2 | 607.48 Million INR | 1.92% |
| 2017 FY | 630.23 Million INR | 13.15% |
| 2017 Q1 | 596.02 Million INR | 7.01% |
| 2017 Q3 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 570.38 Million INR | 0.0% |
| 2016 FY | 557 Million INR | 10.2% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 557 Million INR | 0.0% |
| 2015 Q2 | 501.38 Million INR | 0.0% |
| 2015 Q4 | 505.44 Million INR | 0.0% |
| 2015 FY | 505.44 Million INR | 45.49% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q1 | - INR | -100.0% |
| 2014 FY | 347.4 Million INR | 127.82% |
| 2014 Q4 | 347.4 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 289.27 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2013 Q4 | 152.49 Million INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 152.49 Million INR | 1.99% |
| 2012 Q4 | 149.51 Million INR | 0.0% |
| 2012 FY | 149.51 Million INR | 0.0% |
| 2010 Q4 | 139.94 Million INR | 0.0% |
| 2010 FY | 139.94 Million INR | 10.08% |
| 2009 FY | 127.13 Million INR | 0.0% |
| 2009 Q4 | 127.13 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Sunil Healthcare Limited | 1.58 Billion INR | 14.983% |
| ANG Lifesciences India Limited | 2.42 Billion INR | 44.417% |
| BDH Industries Limited | 934.11 Million INR | -44.257% |
| DECIPHER LABS LIMITED | 336.33 Million INR | -300.654% |
| Gujarat Themis Biosyn Limited | 2.21 Billion INR | 39.057% |
| Jenburkt Pharmaceuticals Limited | 1.65 Billion INR | 18.381% |
| Patidar Buildcon Limited | 94.27 Million INR | -1329.34% |
| Add-Shop E-Retail Limited | 1.25 Billion INR | -6.985% |
| Cian Healthcare Limited | 1.61 Billion INR | 16.394% |
| Concord Drugs Limited | 588.06 Million INR | -129.146% |
| Gujarat Terce Laboratories Limited | 232.73 Million INR | -478.995% |
| Sastasundar Ventures Limited | 11.49 Billion INR | 88.278% |
| Source Natural Foods and Herbal Supplements Limited | 236.5 Million INR | -469.761% |
| Syschem (India) Limited | 1.64 Billion INR | 17.848% |
| Medi-Caps Limited | 1.27 Billion INR | -5.867% |
| Parmax Pharma Limited | 176.12 Million INR | -665.09% |
| Smruthi Organics Limited | 1.18 Billion INR | -14.013% |
| Phaarmasia Limited | 314.47 Million INR | -328.496% |
| Tyche Industries Limited | 1.36 Billion INR | 1.568% |
| Zenith Healthcare Limited | 97.41 Million INR | -1283.311% |
| Denis Chem Lab Limited | 1.09 Billion INR | -23.232% |
| Kwality Pharmaceuticals Limited | 3.94 Billion INR | 65.817% |
| Panchsheel Organics Limited | 1.59 Billion INR | 15.279% |
| Vivanza Biosciences Limited | 195.01 Million INR | -590.989% |
| Bacil Pharma Limited | 13.26 Million INR | -10061.564% |
| Beryl Drugs Limited | 174.86 Million INR | -670.591% |
| Chemo Pharma Laboratories Limited | 130.15 Million INR | -935.347% |
| Colinz Laboratories Limited | 113.59 Million INR | -1086.264% |
| Deccan Health Care Limited | 1.08 Billion INR | -24.715% |
| Hindustan Bio Sciences Limited | 33.74 Million INR | -3893.494% |
| Ishita Drugs and Industries Limited | 108.08 Million INR | -1146.704% |
| KIMIA BIOSCIENCES LIMITED | 999.66 Million INR | -34.798% |
| Makers Laboratories Limited | 1.61 Billion INR | 16.436% |
| MedPlus Health Services Limited | 30.04 Billion INR | 95.515% |
| Mercury Laboratories Limited | 679.57 Million INR | -98.29% |
| Parnax Lab Limited | 1.88 Billion INR | 28.614% |
| PRAVEG LIMITED | 3.64 Billion INR | 63.04% |
| Sanjivani Paranteral Limited. | 434.05 Million INR | -210.452% |
| SHAMROCK INDUSTRIAL CO.LTD. | 17.6 Million INR | -7555.957% |
| SUDARSHAN PHARMA INDUSTRIES LI | 2.83 Billion INR | 52.405% |
| Trident Lifeline Limited | 870.76 Million INR | -54.752% |
| Transchem Limited | 763.18 Million INR | -76.567% |
| Trinity League India Limited | 32.38 Million INR | -4060.826% |
| Vikram Thermo (India) Limited | 1.42 Billion INR | 5.553% |
| Vista Pharmaceuticals Limited | 579.79 Million INR | -132.416% |
| Zenlabs Ethica Limited | 402.58 Million INR | -234.719% |
| SHELTER PHARMA LIMITED | 379.14 Million INR | -255.409% |
| Vasundhara Rasayans Limited | 373.03 Million INR | -261.238% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1.88 Billion INR | 28.569% |
| Roopa Industries Limited | 647.82 Million INR | -108.009% |
| PANJON LTD. | 173.91 Million INR | -674.832% |
| Pharmaids Pharmaceuticals Limited | 913.4 Million INR | -47.527% |
| TIAAN CONSUMER LIMITED | 95.12 Million INR | -1316.598% |
| Anuh Pharma Limited | 4.45 Billion INR | 69.765% |
| Crestchem Limited | 71.44 Million INR | -1786.18% |
| Emmessar Biotech & Nutrition Limited | 87.42 Million INR | -1441.279% |
| Sandu Pharmaceuticals Limited | 524.14 Million INR | -157.088% |
| Fredun Pharmaceuticals Limited | 3.07 Billion INR | 56.192% |
| Trimurthi Limited | 73.64 Million INR | -1729.657% |
| Shukra Pharmaceuticals Limited | 778.37 Million INR | -73.121% |
| Norris Medicines Limited | 141.87 Million INR | -849.81% |
| Veerhealth Care Limited | 281.16 Million INR | -379.26% |
| Lactose (India) Limited | 1 Billion INR | -33.764% |
| OXYGENTA PHARMACEUTICAL LIMITE | 631.92 Million INR | -113.243% |
| Ambalal Sarabhai Enterprises Limited | 2.5 Billion INR | 46.148% |
| Gennex Laboratories Limited | 2.29 Billion INR | 41.408% |
| Zenotech Laboratories Limited | 1.06 Billion INR | -26.878% |
| Shree Ganesh Remedies Limited | 1.7 Billion INR | 21.167% |
| Bharat Parenterals Limited | 5.03 Billion INR | 73.254% |
| Coral Laboratories Limited | 2.05 Billion INR | 34.485% |
| Evoq Remedies Limited | 368.61 Million INR | -265.569% |
| Kerala Ayurveda Limited | 1.4 Billion INR | 4.361% |
| KOBO BIOTECH LIMITED | 713.93 Million INR | -88.746% |
| Natural Capsules Limited | 3.76 Billion INR | 64.212% |
| Auro Laboratories Limited | 852.67 Million INR | -58.034% |